Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Antiretroviral Therapy market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Antiretroviral Therapymarket, defines the market attractiveness level of Antiretroviral Therapy market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Antiretroviral Therapy industry, describes the types of Antiretroviral Therapy market, the applications of major players and the market size, and deeply analyzes the current situation of the global Antiretroviral Therapy market and the development prospects and opportunities of Antiretroviral Therapy industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Antiretroviral Therapy market in Chapter 13.
By Player:
Abbvie
Bionor Pharma
Boehringer Ingelheim
Mylan
F Hoffmann-La Roche
Janssen Pharmaceuticals
ViiV Healthcare
Vertex Pharmaceuticals
Gilead
By Type:
NNRTIs
NRTI
Multiclass Combination Products
Integrase Inhibitors
By End-User:
Hospital
Clinic
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Antiretroviral Therapy Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Antiretroviral Therapy Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Antiretroviral Therapy Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Antiretroviral Therapy Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Antiretroviral Therapy Market Analysis and Outlook to 2022
-
7.1 Global Antiretroviral Therapy Consumption (2017-2022)
-
7.2 United States Antiretroviral Therapy Consumption (2017-2022)
-
7.3 Europe Antiretroviral Therapy Consumption (2017-2022)
-
7.4 China Antiretroviral Therapy Consumption (2017-2022)
-
7.5 Japan Antiretroviral Therapy Consumption (2017-2022)
-
7.6 India Antiretroviral Therapy Consumption (2017-2022)
-
7.7 South Korea Antiretroviral Therapy Consumption (2017-2022)
8 Region and Country-wise Antiretroviral Therapy Market Analysis and Outlook to 2028
-
8.1 Global Antiretroviral Therapy Consumption Forecast (2022-2028)
-
8.2 United States Antiretroviral Therapy Consumption Forecast (2022-2028)
-
8.3 Europe Antiretroviral Therapy Consumption Forecast (2022-2028)
-
8.4 China Antiretroviral Therapy Consumption Forecast (2022-2028)
-
8.5 Japan Antiretroviral Therapy Consumption Forecast (2022-2028)
-
8.6 India Antiretroviral Therapy Consumption Forecast (2022-2028)
-
8.7 South Korea Antiretroviral Therapy Consumption Forecast (2022-2028)
9 Global Antiretroviral Therapy Market Outlook by Types and Applications to 2022
-
9.1 Global Antiretroviral Therapy Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global NNRTIs Consumption and Growth Rate (2017-2022)
-
9.1.2 Global NRTI Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Multiclass Combination Products Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Integrase Inhibitors Consumption and Growth Rate (2017-2022)
-
9.2 Global Antiretroviral Therapy Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Antiretroviral Therapy Market Outlook by Types and Applications to 2028
-
10.1 Global Antiretroviral Therapy Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global NNRTIs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global NRTI Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Multiclass Combination Products Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Integrase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Antiretroviral Therapy Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Antiretroviral Therapy Import and Export Analysis (Top 5 Countries)
-
11.1 Global Antiretroviral Therapy Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Antiretroviral Therapy Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Antiretroviral Therapy Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Antiretroviral Therapy Market Competitive Analysis
-
14.1 Abbvie
-
14.1.1 Abbvie Company Details
-
14.1.2 Abbvie Antiretroviral Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Abbvie Antiretroviral Therapy Product and Service
-
14.2 Bionor Pharma
-
14.2.1 Bionor Pharma Company Details
-
14.2.2 Bionor Pharma Antiretroviral Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Bionor Pharma Antiretroviral Therapy Product and Service
-
14.3 Boehringer Ingelheim
-
14.3.1 Boehringer Ingelheim Company Details
-
14.3.2 Boehringer Ingelheim Antiretroviral Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Boehringer Ingelheim Antiretroviral Therapy Product and Service
-
14.4 Mylan
-
14.4.1 Mylan Company Details
-
14.4.2 Mylan Antiretroviral Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Mylan Antiretroviral Therapy Product and Service
-
14.5 F Hoffmann-La Roche
-
14.5.1 F Hoffmann-La Roche Company Details
-
14.5.2 F Hoffmann-La Roche Antiretroviral Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 F Hoffmann-La Roche Antiretroviral Therapy Product and Service
-
14.6 Janssen Pharmaceuticals
-
14.6.1 Janssen Pharmaceuticals Company Details
-
14.6.2 Janssen Pharmaceuticals Antiretroviral Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Janssen Pharmaceuticals Antiretroviral Therapy Product and Service
-
14.7 ViiV Healthcare
-
14.7.1 ViiV Healthcare Company Details
-
14.7.2 ViiV Healthcare Antiretroviral Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 ViiV Healthcare Antiretroviral Therapy Product and Service
-
14.8 Vertex Pharmaceuticals
-
14.8.1 Vertex Pharmaceuticals Company Details
-
14.8.2 Vertex Pharmaceuticals Antiretroviral Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Vertex Pharmaceuticals Antiretroviral Therapy Product and Service
-
14.9 Gilead
-
14.9.1 Gilead Company Details
-
14.9.2 Gilead Antiretroviral Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Gilead Antiretroviral Therapy Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Antiretroviral Therapy
-
Figure Antiretroviral Therapy Picture
-
Table Global Antiretroviral Therapy Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Antiretroviral Therapy Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Antiretroviral Therapy Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Antiretroviral Therapy Consumption by Country (2017-2022)
-
Figure United States Antiretroviral Therapy Consumption and Growth Rate (2017-2022)
-
Table Europe Antiretroviral Therapy Consumption and Growth Rate (2017-2022)
-
Figure China Antiretroviral Therapy Consumption and Growth Rate (2017-2022)
-
Figure Japan Antiretroviral Therapy Consumption and Growth Rate (2017-2022)
-
Figure India Antiretroviral Therapy Consumption and Growth Rate (2017-2022)
-
Figure South Korea Antiretroviral Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Antiretroviral Therapy Consumption Forecast by Country (2022-2028)
-
Figure United States Antiretroviral Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Antiretroviral Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Antiretroviral Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Antiretroviral Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Antiretroviral Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Antiretroviral Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global NNRTIs Consumption and Growth Rate (2017-2022)
-
Figure Global NRTI Consumption and Growth Rate (2017-2022)
-
Figure Global Multiclass Combination Products Consumption and Growth Rate (2017-2022)
-
Figure Global Integrase Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global NNRTIs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global NRTI Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Multiclass Combination Products Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Integrase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Antiretroviral Therapy Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Antiretroviral Therapy Export by Region (Top 5 Countries) (2017-2028)
-
Table Abbvie (Foundation Year, Company Profile and etc.)
-
Table Abbvie Antiretroviral Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbvie Antiretroviral Therapy Product and Service
-
Table Bionor Pharma (Foundation Year, Company Profile and etc.)
-
Table Bionor Pharma Antiretroviral Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bionor Pharma Antiretroviral Therapy Product and Service
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim Antiretroviral Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Antiretroviral Therapy Product and Service
-
Table Mylan (Foundation Year, Company Profile and etc.)
-
Table Mylan Antiretroviral Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan Antiretroviral Therapy Product and Service
-
Table F Hoffmann-La Roche (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-La Roche Antiretroviral Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Antiretroviral Therapy Product and Service
-
Table Janssen Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Janssen Pharmaceuticals Antiretroviral Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Janssen Pharmaceuticals Antiretroviral Therapy Product and Service
-
Table ViiV Healthcare (Foundation Year, Company Profile and etc.)
-
Table ViiV Healthcare Antiretroviral Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table ViiV Healthcare Antiretroviral Therapy Product and Service
-
Table Vertex Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Vertex Pharmaceuticals Antiretroviral Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Vertex Pharmaceuticals Antiretroviral Therapy Product and Service
-
Table Gilead (Foundation Year, Company Profile and etc.)
-
Table Gilead Antiretroviral Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Antiretroviral Therapy Product and Service
-
